Effect of Remote Ischemic Preconditioning on Platelet Activation Induced by Coronary Procedures.

[1]  A. Redington,et al.  Remote Ischemic Conditioning , 2017, Journal of cardiovascular pharmacology and therapeutics.

[2]  F. Crea,et al.  Effect of Remote Ischemic Preconditioning on Platelet Activation and Reactivity Induced by Ablation for Atrial Fibrillation , 2014, Circulation.

[3]  F. N. van de Vosse,et al.  Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention , 2012, Journal of thrombosis and haemostasis : JTH.

[4]  F. Crea,et al.  Upper arm intermittent ischaemia reduces exercise-related increase of platelet reactivity in patients with obstructive coronary artery disease , 2011, Heart.

[5]  D. Newby,et al.  Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia–reperfusion injury in humans , 2011, Journal of thrombosis and haemostasis : JTH.

[6]  C. Terkelsen,et al.  Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial , 2010, The Lancet.

[7]  P. Ferdinandy,et al.  Protective effect of ischaemic preconditioning on ischaemia/reper-fusion-induced microvascular obstruction determined by online measurements of coronary pressure and blood flow in pigs , 2009, Thrombosis and Haemostasis.

[8]  F. Crea,et al.  Brief low-workload myocardial ischaemia induces protection against exercise-related increase of platelet reactivity in patients with coronary artery disease , 2009, Heart.

[9]  N. Kleiman,et al.  Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. , 2009, The American journal of cardiology.

[10]  G. Patti,et al.  Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. , 2008, Journal of the American College of Cardiology.

[11]  K. Node,et al.  Increased circulating platelet-derived microparticles are associated with stent-induced vascular inflammation. , 2008, Atherosclerosis.

[12]  C. Yancy,et al.  Thrombosis in Coronary Drug-Eluting Stents: Report From the Meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7–8, 2006* , 2007, Circulation.

[13]  David B Matchar,et al.  Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. , 2007, JAMA.

[14]  A. Fattorossi,et al.  Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise. , 2007, Thrombosis research.

[15]  A. Michelson,et al.  Preconditioning ischemia attenuates molecular indices of platelet activation‐aggregation , 2006, Journal of thrombosis and haemostasis : JTH.

[16]  I. Iakovou,et al.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.

[17]  A. Redington,et al.  Transient Limb Ischemia Induces Remote Ischemic Preconditioning In Vivo , 2002, Circulation.

[18]  A. Blann,et al.  Immediate and late effects of coronary angiography on soluble endothelial cell markers and P-selectin in patients with and without coronary artery disease. , 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[19]  F. Crea,et al.  Ischemic preconditioning in humans: models, mediators, and clinical relevance. , 1999, Circulation.

[20]  J. Zweier,et al.  Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. , 1997, Journal of the American College of Cardiology.

[21]  C. Smith,et al.  Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? , 1995, Journal of the American College of Cardiology.

[22]  F. Gries,et al.  PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) , 1996, European heart journal.

[23]  B. Bull,et al.  An analysis of platelet activation and aggregation produced by three classes of contrast media. , 1995, Journal of vascular and interventional radiology : JVIR.

[24]  A. Goodall,et al.  Profound Platelet Degranulation Is an Important Side Effect of Some Types of Contrast Media Used in Interventional Cardiology , 1993, Circulation.

[25]  P. Teirstein,et al.  Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.